Elegen Corporation, a leading name in the biotechnology sector, is headquartered in the United States and operates extensively across North America and Europe. Founded in 2015, Elegen has rapidly established itself as a pioneer in the field of synthetic biology, focusing on innovative solutions for DNA synthesis and gene editing. The company’s core offerings include high-fidelity DNA synthesis and advanced gene assembly services, distinguished by their speed and accuracy. Elegen's commitment to quality and efficiency has positioned it as a trusted partner for researchers and companies in pharmaceuticals, agriculture, and synthetic biology. With a strong emphasis on technological advancement, Elegen continues to achieve significant milestones, solidifying its reputation as a key player in the biotechnology landscape.
How does Elegen Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Elegen Corporation's score of 23 is lower than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Elegen Corporation, headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Elegen Corporation may still be in the early stages of developing its climate strategy or reporting framework. In the context of industry standards, it is essential for companies to establish clear carbon reduction commitments and transparent reporting practices to align with global climate goals. As of now, Elegen Corporation has not inherited any emissions data from a parent or related organization, nor does it participate in initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). Moving forward, Elegen Corporation may benefit from setting measurable climate commitments and engaging in industry initiatives to enhance its sustainability profile and contribute to broader climate action efforts.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Elegen Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

